Cimzia

Product manufactured by Ucb, Inc.

Application Nr Approved Date Route Status External Links
BLA125160 None None None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Cimzia Is A Tumor Necrosis Factor (tnf) Blocker Indicated For: Reducing Signs And Symptoms Of Crohn's Disease And Maintaining Clinical Response In Adult Patients With Moderately To Severely Active Disease Who Have Had An Inadequate Response To Conventional Therapy (1.1) Treatment Of Adults With Moderately To Severely Active Rheumatoid Arthritis (1.2) Treatment Of Adult Patients With Active Psoriatic Arthritis. (1.3) Treatment Of Adults With Active Ankylosing Spondylitis (1.4) 1.1 Crohn's Disease Cimzia Is Indicated For Reducing Signs And Symptoms Of Crohn's Disease And Maintaining Clinical Response In Adult Patients With Moderately To Severely Active Disease Who Have Had An Inadequate Response To Conventional Therapy. 1.2 Rheumatoid Arthritis Cimzia Is Indicated For The Treatment Of Adults With Moderately To Severely Active Rheumatoid Arthritis (ra). 1.3 Psoriatic Arthritis Cimzia Is Indicated For The Treatment Of Adult Patients With Active Psoriatic Arthritis (psa). 1.4 Ankylosing Spondylitis Cimzia Is Indicated For The Treatment Of Adults With Active Ankylosing Spondylitis (as). [see Clinical Studies (14.4)]

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Certolizumab Pegol

Comments